Skip to main content
Top
Published in: Child's Nervous System 3/2018

01-03-2018 | Original Paper

miR-498 promotes cell proliferation and inhibits cell apoptosis in retinoblastoma by directly targeting CCPG1

Authors: Ling Yang, Ning Wei, Li Wang, Xiang Wang, Qing-Huai Liu

Published in: Child's Nervous System | Issue 3/2018

Login to get access

Abstract

Purpose

Retinoblastoma (Rb) is the most common intraocular tumor in children. MicroRNAs (miRNAs) play a crucial role in gene regulation and cell growth/apoptosis/differentiation. The current study aimed to investigate the role of miR-498 in Rb.

Methods

Quantitative real-time polymerase chain reaction (QRT-PCR) was used to test mRNA level of miR-498. http://​www.​targetscan.​org and http://​www.​microrna.​org were applied to predict target of miR-498. Dual-luciferase reporter assay was applied to investigate if miR-498 targeted cell cycle progression 1 (CCPG1). Western blot (WB) was carried out to assess CCPG1 protein levels. 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay was used to evaluate cell proliferation. Annexin-V Fluorescein (FITC) was adopted to explore cell apoptosis.

Results

In Y79 cells, miR-498 was higher than in normal ARPE-19 cells. MiR-498 could recognize CCPG1-3′ untranslated region (UTR). CCPG1 protein level was remarkably decreased when overexpressed miR-498, nevertheless, significantly increased when inhibiting miR-498. Y79 cells that were transfected with miR-498 mimics manifested notable cell apoptosis down-regulation and cell proliferation promotion; whereas, those transfected with miR-498 inhibitor displayed significant cell apoptosis up-regulation and cell proliferation inhibition compared with control group.

Conclusion

Taken together, miR-498 promotes cell proliferation and inhibits cell apoptosis in Rb by directly targeting CCPG1.
Literature
1.
go back to reference American Cancer Society (2003) Neoplasms of the Eye. Cancer Medicine. Hamilton, Ontario: BC Decker Inc 85 American Cancer Society (2003) Neoplasms of the Eye. Cancer Medicine. Hamilton, Ontario: BC Decker Inc 85
2.
go back to reference Bagnyukova TV, Pogribny IP, Chekhun VF (2006) MicroRNAs in normal and cancer cells: a new class of gene expression regulators. Exp Oncol 28:263–269PubMed Bagnyukova TV, Pogribny IP, Chekhun VF (2006) MicroRNAs in normal and cancer cells: a new class of gene expression regulators. Exp Oncol 28:263–269PubMed
3.
go back to reference Balmer A, Zografos L, Munier F (2006) Diagnosis and current management of retinoblastoma. Oncogene 25:5341–5349CrossRef Balmer A, Zografos L, Munier F (2006) Diagnosis and current management of retinoblastoma. Oncogene 25:5341–5349CrossRef
4.
go back to reference Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRef Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRef
5.
go back to reference Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766–770CrossRef Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766–770CrossRef
6.
go back to reference Broaddus E, Topham A, Singh AD (2009) Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol 93:21–23CrossRef Broaddus E, Topham A, Singh AD (2009) Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol 93:21–23CrossRef
7.
go back to reference Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779–784CrossRef Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779–784CrossRef
8.
go back to reference Chen D, Livne-Bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R (2004) Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5:539–551CrossRef Chen D, Livne-Bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R (2004) Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5:539–551CrossRef
9.
go back to reference Cong J, Liu R, Wang X, Wang J, Wang H, Hou J (2015) Low miR-498 expression levels are associated with poor prognosis in ovarian cancer. Eur Rev Med Pharmacol Sci 19:4762–4765PubMed Cong J, Liu R, Wang X, Wang J, Wang H, Hou J (2015) Low miR-498 expression levels are associated with poor prognosis in ovarian cancer. Eur Rev Med Pharmacol Sci 19:4762–4765PubMed
10.
go back to reference Deng S, Calin GA, Croce CM, Coukos G, Zhang L (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7:2643–2646CrossRef Deng S, Calin GA, Croce CM, Coukos G, Zhang L (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7:2643–2646CrossRef
11.
go back to reference Doe JM (2008) MicroRNA: cancer and future treatment applications. Basic Biotech e J 36–42 Doe JM (2008) MicroRNA: cancer and future treatment applications. Basic Biotech e J 36–42
12.
go back to reference Du W, Pogoriler J (2006) Retinoblastoma family genes. Oncogene 25:5190–5200CrossRef Du W, Pogoriler J (2006) Retinoblastoma family genes. Oncogene 25:5190–5200CrossRef
13.
14.
go back to reference Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259–269CrossRef Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259–269CrossRef
15.
go back to reference Faghihi MA, Kocerha J, Modarresi F, Engström PG, Chalk AM, Brothers SP, Koesema E, St Laurent G, Wahlestedt C (2010) RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS One 5:e13177CrossRef Faghihi MA, Kocerha J, Modarresi F, Engström PG, Chalk AM, Brothers SP, Koesema E, St Laurent G, Wahlestedt C (2010) RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS One 5:e13177CrossRef
16.
17.
go back to reference Hobert O (2008) Gene regulation by transcription factors and microRNAs. Science 319:1785–1786CrossRef Hobert O (2008) Gene regulation by transcription factors and microRNAs. Science 319:1785–1786CrossRef
18.
go back to reference Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283:83–87CrossRef Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283:83–87CrossRef
19.
go back to reference Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820–823CrossRef Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820–823CrossRef
20.
go back to reference Liu R, Liu F, Li L, Sun M, Chen K (2015) MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells. Biomed Pharmacother 72:52–57CrossRef Liu R, Liu F, Li L, Sun M, Chen K (2015) MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells. Biomed Pharmacother 72:52–57CrossRef
21.
go back to reference Lohmann DR, Gallie BL (2004) Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 129C:23–28CrossRef Lohmann DR, Gallie BL (2004) Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 129C:23–28CrossRef
22.
go back to reference MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, Onadim Z, Stiller CA, Vincent TJ, Murphy MF (2009) Retinoblastoma in Great Britain 1963–2002. Br J Ophthalmol 93:33–37CrossRef MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, Onadim Z, Stiller CA, Vincent TJ, Murphy MF (2009) Retinoblastoma in Great Britain 1963–2002. Br J Ophthalmol 93:33–37CrossRef
23.
go back to reference MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE (2006) Retinoblastoma incidence and survival in European children (1978–1997). Report from the automated childhood cancer information system project. Eur J Cancer 42:2092–2102CrossRef MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE (2006) Retinoblastoma incidence and survival in European children (1978–1997). Report from the automated childhood cancer information system project. Eur J Cancer 42:2092–2102CrossRef
24.
go back to reference Pfeffer S, Voinnet O (2006) Viruses, microRNAs and cancer. Oncogene 25:6211–6219CrossRef Pfeffer S, Voinnet O (2006) Viruses, microRNAs and cancer. Oncogene 25:6211–6219CrossRef
25.
go back to reference Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sørensen FJ, Kruhoffer M, Laurberg S, Kauppinen S, Orntoft TF, Andersen CL (2008) Diagnostic and prognostic MicroRNAs in stage II colon cancer. Cancer Res 68:6416–6424CrossRef Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sørensen FJ, Kruhoffer M, Laurberg S, Kauppinen S, Orntoft TF, Andersen CL (2008) Diagnostic and prognostic MicroRNAs in stage II colon cancer. Cancer Res 68:6416–6424CrossRef
26.
go back to reference Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139CrossRef Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139CrossRef
27.
go back to reference Ventura A, Jacks T (2009) MicroRNAs and cancer. Short RNAs go a long way. Cell 136:586–591CrossRef Ventura A, Jacks T (2009) MicroRNAs and cancer. Short RNAs go a long way. Cell 136:586–591CrossRef
28.
go back to reference Wang M, Zhang Q, Wang J, Zhai Y (2015) MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression. J Cancer Res Ther 11:C107–C111CrossRef Wang M, Zhang Q, Wang J, Zhai Y (2015) MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression. J Cancer Res Ther 11:C107–C111CrossRef
29.
go back to reference Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Investig 88:1358–1366CrossRef Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Investig 88:1358–1366CrossRef
30.
go back to reference Zhao JJ, Yang J, Lin JH, Yao N, Zhu YH, Zheng JH, JH X, Cheng JQ, Lin JY, Ma X (2009) Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25:13–20CrossRef Zhao JJ, Yang J, Lin JH, Yao N, Zhu YH, Zheng JH, JH X, Cheng JQ, Lin JY, Ma X (2009) Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25:13–20CrossRef
Metadata
Title
miR-498 promotes cell proliferation and inhibits cell apoptosis in retinoblastoma by directly targeting CCPG1
Authors
Ling Yang
Ning Wei
Li Wang
Xiang Wang
Qing-Huai Liu
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 3/2018
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-017-3622-8

Other articles of this Issue 3/2018

Child's Nervous System 3/2018 Go to the issue